ACMR ACM Research, Inc.
Special Industry Machinery, NEC · Nasdaq · SEC CIK 1680062 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY29.1%
TTM net income YoY-1.0%
TTM EPS YoY-7.0%
Revenue 3-yr CAGR31.8%
Net income 3-yr CAGR17.5%
Margins
Gross margin43.5%
Operating margin14.5%
Net margin10.2%
FCF margin-17.5%
EBITDA margin16.5%
Returns
ROE7.0%
ROA3.6%
ROIC (approx.)15.5%
Asset turnover0.36x
Leverage & solvency
Liabilities / assets31.3%
Debt / equity0.11x
Current ratio3.16x
Interest coverage22.37x
Cash quality & payout
Operating cash flow / net income-0.62x
Accruals ratio5.9%
Payout ratio—
Capex / revenue11.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $901.31M | $782.12M |
| Cost of revenue | $501.24M | $390.56M |
| Gross profit | $400.07M | $391.55M |
| R&D expense | $144.99M | $105.47M |
| SG&A expense | $68.75M | $69.64M |
| Operating income | $109.43M | $151.00M |
| Interest expense | $6.96M | $4.15M |
| Pretax income | $135.19M | $166.30M |
| Income tax | $13.30M | $35.03M |
| Net income | $94.08M | $103.63M |
| EBITDA | $123.83M | $157.57M |
| EPS (basic) | 1.47 | 1.67 |
| EPS (diluted) | 1.37 | 1.53 |
| Weighted avg. shares (diluted) | 67.31M | 66.24M |
| Balance sheet | ||
| Cash & equivalents | $757.37M | $411.31M |
| Short-term investments | $35.52M | $19.37M |
| Receivables | $504.25M | $387.05M |
| Inventory | $702.63M | $597.98M |
| Current assets | $2.44B | $1.48B |
| PP&E, net | $314.83M | $269.27M |
| Intangibles | $2.85M | $3.46M |
| Total assets | $2.87B | $1.86B |
| Current liabilities | $745.71M | $641.23M |
| Short-term debt | $35.08M | $44.47M |
| Long-term debt | $178.93M | $105.53M |
| Total debt | $214.01M | $150.00M |
| Total liabilities | $941.68M | $759.82M |
| Shareholders' equity | $1.46B | $904.62M |
| Net debt | -$543.36M | -$261.31M |
| Cash flow statement | ||
| Operating cash flow | -$10.32M | $152.45M |
| Capital expenditure | $56.28M | $82.46M |
| Free cash flow | -$66.61M | $69.99M |
| Investing cash flow | -$390.33M | -$11.96M |
| Financing cash flow | $742.49M | $92.48M |
| Depreciation & amortization | $14.40M | $6.57M |
| Stock-based compensation | $33.58M | $49.58M |
Free plan shows the latest 2 periods; Pro shows all 10 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.